期刊文献+

青岛地区高尿酸血症患者的肠道菌群分析 被引量:27

Analysis of intestinal flora in patients with hyperuricemia in Qindao District
原文传递
导出
摘要 目的 观察青岛地区高尿酸血症患者肠道菌群的变化及菌群对尿酸处理能力的相关性分析.方法 收集2013年1月至2013年6月在本院内分泌门诊就诊的高尿酸血症患者30例(男28例,女2例)及同期在健康查体中心查体的健康对照组粪便标本20例(男16例,女4例).应用细菌培养方法进行粪便菌群分析,运用酶比色法检测不同组粪便中细菌分解前后尿酸含量变化,磷钨酸法检测血尿酸水平.结果 高尿酸血症患者肠道菌群发生变化,表现为总需氧菌(7.76 ±0.67,P<0.05)、大肠杆菌(7.58 ±0.34,P<0.05)及拟杆菌(2.75 ±0.31,P<0.05)增加,乳酸杆菌(2.69±1.48,P<0.05)及双歧杆菌(5.38 ±0.34,P<0.05)数目减少.血及粪便中尿酸含量升高(P<0.05),粪便菌群尿酸处理能力与健康对照组比较差异无统计学意义(P>0.05).粪便菌群尿酸分解活性主要与乳酸杆菌及双歧杆菌含量呈正相关(r =0.565,0.328,P<0.05).结论 青岛地区高尿酸血症患者肠道菌群存在失调现象,粪便菌群尿酸处理能力与乳酸杆菌及双歧杆菌含量有关.菌群失调可能参与高尿酸血症的发病过程. Objective To investigate the variations of intestinal flora of common carp in patients with hyperuricemia in Qingdao District.Methods The fecal flora was analyzed by gradient dilution method.The levels of uric acid in blood and feces were detected by enzyme colorimetry method and phosphortungstic acid method,respectively.Results E.coli (7.58 ± 0.34,P < 0.05),the total count of aerobian (7.76 ± 0.67,P < 0.05),and bacteroides (2.75 ± 0.31,P < 0.05) were significantly increased in hyperuricemia patients compared to controls.Bifidobacterium (5.38 ± 0.34,P < 0.05) and lactobacillus (2.69 ± 1.48,P < 0.05) were sig-nificantly decreased compared to controls.Concentrations of uric acid in blood and feces were both significantly higher in the patients relative to healthy controls.Decomposition capability was similar to healthy controls.Decomposition capability of uric acid revealed a close correlation with bifidobacterium and lactobacillus,respectively (r =0.565,0.328,P < 0.05).Conclusions Intestinal dysbacteriosis was found by the analysis of fecal flora in patient with hyperuricemia in Qingdao district.Dysbacteriosis might participate in the process of hyperuricemia onset.
出处 《中国医师杂志》 CAS 2014年第12期1649-1651,1656,共4页 Journal of Chinese Physician
关键词 高尿酸血症 肠/微生物学 有益菌种/治疗应用 尿酸 Hyperuricemia Intestines/microbiology Probiotics/therapeutic use Uric acid
  • 相关文献

参考文献15

  • 1Ofori SN, Odia OJ. Serum uric acid and target organ damage in essential hypertension [ J ]. Vasc Health Risk Manag, 2014 , (10) :253-261.
  • 2Kontogianni MD, Chrysohoou C, Panagiotakos DB, et al. Adher- ence to the Mediterranean diet and serum uric acid: the ATYICA study [ J ]. Scand J Rheumatol, 2012,41 (6) :442449.
  • 3徐明艳,周飞,于淼,杨继英,张秀坤.老年糖尿病患者高尿酸血症与胰岛素抵抗的关系探讨[J].中国基层医药,2014,21(3):324-325. 被引量:2
  • 4Hediger MA, Johnson R J, Miyazaki H, et al. Mo|ecular Physiolo- gy of Urate Transport[J]. Physiology,2005, 20(2) :125-133.
  • 5Hosomi A, Nakanishi T, Fujita T, et al. Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2 [ J ]. PLoS One, 2012,7(2) :e30456.
  • 6程晓宇,苗志敏,刘柳,韩琳,李长贵.青岛居民膳食习惯与痛风性关节炎关系分析[J].青岛大学医学院学报,2012,48(2):95-97. 被引量:11
  • 7Vitetta L, Gobe G. Uremia and chronic kidney disease : the role Of the gut microflora and therapies with pro- and prebiotics [ J 1. Mol Nutr Food Res ,2013, 57 ( 5 ) : 824-832.
  • 8杨殿斌,袁杰利.降血尿酸乳酸菌筛选及其对高尿酸血症模型大鼠作用研究[J].中国微生态学杂志,2013,25(2):125-128. 被引量:9
  • 9Bai YH, Jiang YF, Jiang YS. Lactobacillus bulgaricus mutants decompose uremic toxins[ J ]. Ren Fail, 20!4 ,36 (5) :790-794.
  • 10Ranganathan N, Ranganathan P, Friedman EA, et al. Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease [ J ]. Adv Ther, 2010,27(9) :634-647.

二级参考文献56

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3046
  • 2陈欣,潘素华,胡黎黎,刘祥,余倩.人源乳酸杆菌耐酸耐胆盐能力的测定和鉴定[J].现代预防医学,2006,33(3):278-279. 被引量:12
  • 3Taki K, Takayama F, Niwa T. Beneficial effects of Bifidobacteria in a gastroresistant seamless capsule on hyperhomocysteinemia in hemodialysis patients[J]. J Ren Nutr, 2005, 15(1): 77 -80.
  • 4Chen M, Lee A, Hazell S, et al. Immunisation against gastric helicobacter infection in a mouse/Helicobacter felis model [J]. Lancet, 1992, 339.(8801): 1120-1121.
  • 5Ranganathan N, Patel B G, Marczely J, et al. Invitro and in vivo assessement of intraintestinal bacteriotherapy in chronic kidney disease [J]. ASAIO J, 2006, 52(1) : 70-79.
  • 6Strahinic I, Busarcevic M, Pavlica D, et al. Molecular and biochemical characterizations of human oral lactobacilli as putative probiotic candidates [ J ]. Oral Microbiol Immunol, 2007,22(2) : 111-117.
  • 7Vizoso Pinto M G, Schuster T, Briviba K, et al. Adhesive and chemokine stimulatory properties of potentially probiotic lactobacillus strains [ J]. J Food Prot, 2007, 70 (1) : 125-134.
  • 8Takayama F, Taki K, Niwa T. Biffidobacterium in gastro-resistent seamless capsule reduces serum levels of indoxyl sulfate in patient on hemodialysis [ J ]. Am J Kidney Dis, 2003,41 ( supp 1 ) : 142-145.
  • 9Simenhoff M L, Dunn S R, Zollner G P, et al. Bismadulation of the toxic and nutritional effects of small bowel bacterical ovrgrowith in end-stage kidney disease using freeze-dried lactobacillus acidophilus [ J ]. Miner Electrolyte Metab,1996, 22(13) : 92-96.
  • 10Ando Y, Miyata Y, Tanba K, et al. Effect of oral intake of an enteric capsule preparation containing Biffidobacterium Iongum on the progression of chronic renal failure [ J ]. Nippon Jinzo Gakkai Shi, 2003, 45 (8) : 759-764.

共引文献41

同被引文献254

引证文献27

二级引证文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部